FierceBiotech

InSite Vision Announces Positive Phase 2 PK Results for BromSite(TM) (ISV-303) for the Reduction of Pain and Inflammation After

ALAMEDA, Calif., Oct 04, 2011 (BUSINESS WIRE) -- InSite Vision Incorporated (INSV) today announced positive top-line results from a Phase 2 pharmacokinetic (PK) clinical study comparing the tissue ...
FierceBiotech

InSite Vision Announces Pricing of $22.2 Million Financing

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) (InSite Vision) today announced that it has entered into definitive agreements with certain accredited investors in connection ...
AOL

InSite Vision to Present Five Scientific Posters at 2013 ARVO Meeting

ALAMEDA, Calif.--(BUSINESS WIRE)-- InSite Vision Incorporated (OTCBB: INSV) today announced that it has sponsored research being presented in five scientific posters at the 2013 Association for ...
Healio

InSite Vision's common stock eligible for trading on the Over-the-Counter Bulletin Board

Please provide your email address to receive an email when new articles are posted on . ALAMEDA, Calif. — InSite Vision announced that its securities are now eligible for trading on the ...
AOL

InSite Vision Regains Development Rights for AzaSite Xtra™

ALAMEDA, Calif.--(BUSINESS WIRE)-- InSite Vision Incorporated (OTCBB: INSV) today announced that the company has regained North American development rights to azithromycin ophthalmic solution 2%, ...
Insider Monkey

Insider Trading: Coliseum Capital Management Sold Some $INSV

Coliseum Capital Management, managed by Christopher Shackelton and Adam Gray, yesterday filed for its insider transaction in Insite Vision Inc. (INSV). The filing reveals that Coliseum Capital ...
Business Wire

InSite Vision Announces Completion of the New Drug Application Submission to the U.S. FDA for BromSite

ALAMEDA, Calif.-- (BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today announced that it has completed the submission to the U.S. Food and Drug Administration (FDA) of the New Drug ...
Healio

QLT to acquire InSite Vision

Please provide your email address to receive an email when new articles are posted on . QLT Inc. will acquire InSite Vision Inc. in an all-stock transaction that will create an ophthalmic specialty ...
The Business Journals

Mystery, intrigue as biotech M&A explodes

From the big showdown for Newark's Depomed to the bidding war for lesser-known InSite Vision of Alameda, mergers and acquisitions in the drug development space are booming. Separated by a mere couple ...
Deccan Chronicle

INSV Kaundinya: Indian Navy Launches Ship Without Engines Or Weapons

Hyderabad: In an age of high-tech warships and stealth submarines, the Indian Navy has done something truly remarkable. It has launched a ship without weapons, without engines, and without even a ...
Business Wire

InSite Vision Announces Positive Phase 1/2 Results for ISV-303 for the Reduction of Pain and Inflammation after Cataract Surgery

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today announced top-line results from its recently completed Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory ...